Literature DB >> 2535853

Adrenergic modulation of adrenocorticotropin responses to insulin-induced hypoglycemia and corticotropin-releasing hormone.

N Tomori1, T Suda, Y Nakagami, F Tozawa, T Sumitomo, T Ushiyama, H Demura, K Shizume.   

Abstract

To study possible adrenergic modulation of pituitary-adrenal responses to insulin-induced hypoglycemia and CRH we examined the effect of nonselective alpha-blockade (phentolamine) and nonselective beta-blockade (propranolol) on plasma ACTH, cortisol, and vasopressin (AVP) responses to hypoglycemia and CRH in five normal men. Infusion of propranolol or phentolamine did not alter basal plasma ACTH or cortisol levels. The propranolol infusion enhanced the stimulatory effect of hypoglycemia on ACTH, cortisol, and AVP secretion and also enhanced the stimulatory effect of CRH on ACTH and cortisol secretion. Infusion of phentolamine inhibited hypoglycemia-induced ACTH and AVP secretion, but had no effect on the stimulatory effect of CRH on ACTH and cortisol secretion. The increments of plasma ACTH and cortisol induced by an almost maximal dose of CRH (1 microgram/kg) were smaller than those induced by hypoglycemia. The propranolol-induced enhancement of the ACTH response to hypoglycemia was almost the same as the ACTH response to CRH alone. From these results we conclude that propranolol may act at the pituitary level to enhance CRH action, rather than AVP action, and that the ACTH response to hypoglycemia may be mediated by hypothalamic alpha-adrenergic activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535853     DOI: 10.1210/jcem-68-1-87

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  Drugs and HPA axis.

Authors:  Alberto Giacinto Ambrogio; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells.

Authors:  L J Muglia; N A Jenkins; D J Gilbert; N G Copeland; J A Majzoub
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  Effects of ritanserin, a specific serotonin-S2 receptor antagonist, on the release of anterior pituitary hormones during insulin-induced hypoglycemia in normal humans.

Authors:  D Tepavcević; Z Giljević; I Aganović; M Korsić; S Halimi; E Suchanek; T Jelić; B Kozić; V Plavsić
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

4.  Adrenergic effects on adrenocortical cortisol response to incremental exercise to exhaustion.

Authors:  A Viru; M Viru; K Karelson; T Janson; K Siim; K Fischer; A C Hackney
Journal:  Eur J Appl Physiol       Date:  2007-03-03       Impact factor: 3.346

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.